Ranivisio 10 mg/ml

Ranivisio 10 mg/ml is a medicine authorised by Swissmedic under authorisation number 70412. The authorisation holder is Bioeq AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 December 2025 and the authorisation is limited until 18 December 2030. ATC code S01LA04 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 70412
  • ATC S01LA04
  • Biotechnological medicines
Authorisation data
Authorisation number70412
NameRanivisio 10 mg/ml
Full nameRanivisio 10 mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderBioeq AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeS01LA04
First authorisation19 December 2025
Authorisation validity18 December 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Ranivisio 10 mg/ml, Injektionslösung in einer FertigspritzeB19 December 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)S01LA0411.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ranivisio 10 mg/ml authorised in Switzerland?

Yes. Ranivisio 10 mg/ml is authorised by Swissmedic under authorisation number 70412, data as of 01 September 2026. The authorisation is limited until 18 December 2030.

Which dispensing category does Ranivisio 10 mg/ml have?

Ranivisio 10 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ranivisio 10 mg/ml?

The authorisation holder is Bioeq AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com